Gts Securities LLC Intra Cellular Therapies, Inc. Transaction History
Gts Securities LLC
- $2.05 Trillion
- Q4 2024
A detailed history of Gts Securities LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Gts Securities LLC holds 4,200 shares of ITCI stock, worth $536,844. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,200Holding current value
$536,844% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ITCI
# of Institutions
415Shares Held
88.5MCall Options Held
284KPut Options Held
105K-
Vanguard Group Inc Valley Forge, PA9.72MShares$1.24 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$808 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.13MShares$655 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$415 Million1.36% of portfolio
-
Norges Bank Oslo, Q83.21MShares$411 Million0.04% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.1B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...